The United Kingdom has announced strict new procedures to ensure diabetes and weight loss -such as Ozmbek, Mongaro and Wigvio -so that they are used only by patients who need them for a medical reason.
This step aims to reduce the incorrect use of these medications, which was originally developed to treat type 2 diabetics and people with obese to help regulate blood sugar levels and enhance weight loss.
The British Pharmacists Organizational Authority announced the inclusion of slimming drugs on the list of high -risk medications, which imposes on them more striking restrictions when prescribed and disbursed, according to the British newspaper “Daily Mail”.
Pharmacies can no longer rely only on the information provided by patients through electronic questionnaires or phone calls. Rather, verification of height, weight and BMI data has become compulsory, And that is through video consulting, personal visits to patients, reviewing medical records, or direct communication with the patient’s doctor.
In addition, all pharmacies have become obligated to verify periodically from the persistence of patients needing the medicine. For its part, the authority explained that pharmacies or practitioners who do not abide by these rules may face investigations on the extent of their commitment to the procedures for practicing the profession, and disciplinary measures have already been taken against more than 12 pharmacists for violating the rules related to the disbursement of these drugs.
The body mass index can be calculated by dividing a person’s weight per kilogram by a square in meter. The BMI is evaluated through the following:
- Less than 18.5: The person suffers from weight loss, which may lead to his weak immune system and increase the risk of bone thinning.
- Lack of weight may be associated with a person suffering from a food disorder.
- 18.5 to 24.9: The weight is normal, which means that there are no health risks associated with weight on a person’s health, with confirmation that this does not mean that there are no health risks related to other matters.
- 25 to 29.9: The person suffers from weight gain.
- 30 and more: The person has obesity.
Using slimming medications
Medical reports raised concerns about the abuse of slimming drugs, as investigations revealed that some electronic pharmacies in the United Kingdom have spent these drugs for people with health weights or do not meet medical standards, and sometimes based on forged information about their weight, which led to a rise in cases of complications Hygiene associated with it.
In response to these concerns, many major pharmacy chains in Britain issued new measures to ensure that these drugs do not reach patients who do not need them, including taking full pictures of the body from the front and from the side with clear dates, making lengthy video consultations of half an hour, and following patients through Later pictures to monitor the progress of treatment and ensure the continuity of the need for the drug.
For those who behave slimming medications?
The instructions of the British National Health Service state that slimming drugs are only spent for patients with obesity, according to the following criteria:
- The BMI is more than 35, with another health problem associated with obesity such as high blood pressure or diabetes.
- The BMI is between 30-34.9, provided that the patient has already tried to lose weight by following a healthy diet and exercising without achieving sufficient results, and that his condition is evaluated accurately.
The British Advertising Standards Authority has already warned companies and promoters, especially those influencing social media, against the illegal promotion of these drugs to the public, stressing that any violation of these laws may lead to strict legal penalties.